These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38445835)

  • 21. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
    Egri N; Bentow C; Rubio L; Norman GL; López-Sañudo S; Mahler M; Pérez-Isidro A; Cervera R; Viñas O; Espinosa G; Ruiz-Ortiz E
    Front Immunol; 2021; 12():754469. PubMed ID: 34790198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis.
    Reynaud Q; Lega JC; Mismetti P; Chapelle C; Wahl D; Cathébras P; Laporte S
    Autoimmun Rev; 2014 Jun; 13(6):595-608. PubMed ID: 24418303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.
    Yelnik CM; Porter TF; Branch DW; Laskin CA; Merrill JT; Guerra MM; Lockshin MD; Buyon JP; Petri M; Sammaritano LR; Stephenson MD; Kim MY; Salmon JE
    Arthritis Rheumatol; 2016 Aug; 68(8):1964-9. PubMed ID: 26990620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome.
    Simchen MJ; Dulitzki M; Rofe G; Shani H; Langevitz P; Schiff E; Pauzner R
    Acta Obstet Gynecol Scand; 2011 Dec; 90(12):1428-33. PubMed ID: 21729009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus.
    Martini F; Farsi A; Gori AM; Boddi M; Fedi S; Domeneghetti MP; Passaleva A; Prisco D; Abbate R
    Lupus; 1996 Jun; 5(3):206-11. PubMed ID: 8803891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus.
    Vista ES; Crowe SR; Thompson LF; Air GM; Robertson JM; Guthridge JM; James JA
    Lupus; 2012 Feb; 21(2):168-74. PubMed ID: 22235049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies.
    Ogishima D; Matsumoto T; Nakamura Y; Yoshida K; Kuwabara Y
    Pathol Int; 2000 Mar; 50(3):224-9. PubMed ID: 10792786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Chock YP; Moulinet T; Dufrost V; Erkan D; Wahl D; Zuily S
    Autoimmun Rev; 2019 Nov; 18(11):102395. PubMed ID: 31520800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome.
    Gattorno M; Buoncompagni A; Molinari AC; Barbano GC; Morreale G; Stalla F; Picco P; Mori PG; Pistoia V
    Br J Rheumatol; 1995 Sep; 34(9):873-81. PubMed ID: 7582730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study.
    Helgadottir LB; Skjeldestad FE; Jacobsen AF; Sandset PM; Jacobsen EM
    Thromb Res; 2012 Jul; 130(1):32-7. PubMed ID: 22178574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of beta-2-glycoprotein-I-dependent antiphospholipid antibodies and anti-beta-2-glycoprotein-I antibody in patients with systemic lupus erythematosus and in patients with syphilis.
    Matsuda J; Saitoh N; Gohchi K; Gotoh M; Tsukamoto M
    Int Arch Allergy Immunol; 1994; 103(3):239-44. PubMed ID: 8111242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Frequency of antiphospholipid syndrome in women with pregnancy loss in multicenter study in Poland].
    Skrzypczak J; Rajewski M; Wirstlein P; Goździewicz T; Zimmer M; Wołczyński S; Leszczyńska-Gorzelak B; Breborowicz G; Ludwikowski G
    Ginekol Pol; 2011 Oct; 82(10):749-54. PubMed ID: 22379938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis.
    Opatrny L; David M; Kahn SR; Shrier I; Rey E
    J Rheumatol; 2006 Nov; 33(11):2214-21. PubMed ID: 17014001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
    Reshetnyak T; Cheldieva F; Cherkasova M; Lila A; Nasonov E
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results.
    Yelnik CM; Laskin CA; Porter TF; Branch DW; Buyon JP; Guerra MM; Lockshin MD; Petri M; Merrill JT; Sammaritano LR; Kim MY; Salmon JE
    Lupus Sci Med; 2016; 3(1):e000131. PubMed ID: 26835148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody.
    Matsuda J; Saitoh N; Gohchi K; Gotoh M; Tsukamoto M
    Am J Hematol; 1994 Sep; 47(1):56-8. PubMed ID: 8042617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.